Clinical Trial Update: Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin [Phase 3]

View source ↗

Summary

Phase 3 study comparing gemigliptin and vildagliptin as add-on therapy to metformin in people with type 2 diabetes inadequately controlled on metformin. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gemigliptin (gemigliptin)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED